Navigation Links
Azantis Announces New Consumer Safety Program

BOULDER, Colo., Oct. 7 /PRNewswire/ -- Marine biotechnology specialist Azantis, Inc. has made a new post-marketing surveillance program available to its clients, in an effort to provide continued high quality service to the consumer.  By entering into an agreement with SafetyCall International, Azantis has partnered with the recognized leader in Adverse Event Management and Post-Market Surveillance services.

SafetyCall medical and toxicology professionals are recognized experts in the collection and interpretation of spontaneously reported incident data.  For the past 25 years, SafetyCall professionals managed over 1.5 million product incident cases, positively impacting the safety of products worldwide.

As a client of SafetyCall, Azantis invites all its clients to place the SafetyCall number on their finished product labels.  In the event of a complaint, incident, or adverse event, the consumer calls the number.  SafetyCall medical professionals engage the consumer, to better understand the nature of the complaint—often interacting directly with the consumer's personal physician.  This depth of case management helps consumers assess whether the event is truly attributable to the product.  Krill oil consumers benefit from the free service, because they can quickly access a medical professional familiar with this class of products, who can address their safety concerns. Azantis krill oil resellers benefit from this service, because they share a strong common safety record, and have an independent professional service assisting them with evaluating any possible adverse medical incident.  

With over 100 million capsules sold, Azantis has an exemplary safety record as krill oil supplier, with no adverse events attributed to its products.  Azantis' bulk krill oil has GRAS (Generally Recognized as Safe) notification status from the Food and Drug Administration.  Our agreement with SafetyCall will formalize our post-market surveillance system and serve as a program that meets the new FDA regulatory requirements.

About Azantis:

Azantis is a biotechnology company located in Boulder, Colorado. The company specializes in discovery and extraction of bioactive molecules from marine and other biomass sources for use in food, nutraceutical, and pharmaceutical products.  Azantis' product offerings include bulk krill oil and bulk krill oil capsules, which contain high quality marine phospholipids with bonded omega-3 fatty acids, esterified astaxanthin, and choline.  Azantis krill oil is derived from krill sustainably harvested under the supervision of the international treaty organization CCAMLR (Convention on the Conservation of Antarctic Marine Living Resources).

SOURCE Azantis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants
2. NCPA Announces Exhibit Hall Activities for 2010 NCPA Annual Convention and Trade Exposition
3. Onyx Pharmaceuticals Announces Teleconference to Provide Status Update on Carfilzomib
4. Nonin Medical Announces Its Second-Generation Wrist-Worn Device for European Distribution: Delivering Reliability in the Widest Range of Patient Populations and Clinical Settings
5. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
6. SpineSmith Partners Announces FDA Clearance and Product Launch of VisuALIF Interbody Fusion Device at North American Spine Society Annual Meeting
7. Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2010 Results
9. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
10. Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets
11. Orthopedics This Week Announces 2010 Best Spine Technology Award Winners
Post Your Comments:
(Date:12/1/2015)... N.J. , Dec. 1, 2015 ... held in San Francisco, CA ... solutions to the coronary marketplace. During a satellite ... in Stent Design to Minimize Restenosis", a renowned ... currently available Medinol NIRxcell™ CoCr Coronary Stent System ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
(Date:12/1/2015)...  InCarda Therapeutics, Inc. (InCarda), a privately-held biopharmaceutical company ... cardiovascular conditions via the inhalation route, today announced that ... Australia . InCarda is planning to undertake its ... in the first half of 2016. The company ... Adelaide and Melbourne.  In addition, ...
Breaking Medicine Technology:
(Date:12/1/2015)... D.C. (PRWEB) , ... December 01, 2015 , ... ... updated, comprehensive website detailing the important role that meat and poultry play ... in meat and poultry, a nutrition quiz where visitors can check their “meat ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated Rental Services (“Integrated ... Industries International, LLC (“JII”). , With support from JII, Integrated Rental is poised ... hospitals, surgery centers, clinics, research labs and medical facilities across the United States. ...
(Date:12/1/2015)... ... 01, 2015 , ... Califia Farms , one of the fastest growing ... won top honors in Beverage World Magazine’s Global Packaging Design Awards, taking home the ... been selected as a 2015 U.S.A. Taste Champion in the American Masters of Taste ...
(Date:12/1/2015)... ... December 01, 2015 , ... December ... seen vast improvements in scientific research and discoveries, leading us to better understand ... and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of ... is the focus of numerous abstracts accepted for presentation here, at the 101st ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools ...
Breaking Medicine News(10 mins):